Morocco
· Delayed Price · Currency is MAD Med Paper Statistics
Total Valuation
Med Paper has a market cap or net worth of MAD 185.85 million. The enterprise value is 379.46 million.
| Market Cap | 185.85M |
| Enterprise Value | 379.46M |
Important Dates
The next estimated earnings date is Friday, September 26, 2025.
| Earnings Date | Sep 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Med Paper has 4.78 million shares outstanding. The number of shares has decreased by -1.23% in one year.
| Current Share Class | 4.78M |
| Shares Outstanding | 4.78M |
| Shares Change (YoY) | -1.23% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 22.99.
| PE Ratio | 22.99 |
| Forward PE | n/a |
| PS Ratio | 1.76 |
| PB Ratio | 5.40 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.32 |
| P/OCF Ratio | 13.74 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 51.69, with an EV/FCF ratio of 31.29.
| EV / Earnings | 47.52 |
| EV / Sales | 3.59 |
| EV / EBITDA | 51.69 |
| EV / EBIT | 61.13 |
| EV / FCF | 31.29 |
Financial Position
The company has a current ratio of 0.96, with a Debt / Equity ratio of 5.64.
| Current Ratio | 0.96 |
| Quick Ratio | 0.70 |
| Debt / Equity | 5.64 |
| Debt / EBITDA | 26.50 |
| Debt / FCF | 16.03 |
| Interest Coverage | 1.88 |
Financial Efficiency
Return on equity (ROE) is 26.23% and return on invested capital (ROIC) is 1.67%.
| Return on Equity (ROE) | 26.23% |
| Return on Assets (ROA) | 1.11% |
| Return on Invested Capital (ROIC) | 1.67% |
| Return on Capital Employed (ROCE) | 3.87% |
| Revenue Per Employee | 233,033 |
| Profits Per Employee | 17,627 |
| Employee Count | 453 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 1.06 |
Taxes
In the past 12 months, Med Paper has paid 277,495 in taxes.
| Income Tax | 277,495 |
| Effective Tax Rate | 3.36% |
Stock Price Statistics
The stock price has increased by +100.73% in the last 52 weeks. The beta is -0.01, so Med Paper's price volatility has been lower than the market average.
| Beta (5Y) | -0.01 |
| 52-Week Price Change | +100.73% |
| 50-Day Moving Average | 28.50 |
| 200-Day Moving Average | 23.45 |
| Relative Strength Index (RSI) | 66.47 |
| Average Volume (20 Days) | 36,554 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Med Paper had revenue of MAD 105.56 million and earned 7.99 million in profits. Earnings per share was 1.69.
| Revenue | 105.56M |
| Gross Profit | 48.95M |
| Operating Income | 6.20M |
| Pretax Income | 8.26M |
| Net Income | 7.99M |
| EBITDA | 7.33M |
| EBIT | 6.20M |
| Earnings Per Share (EPS) | 1.69 |
Balance Sheet
The company has 762,388 in cash and 194.37 million in debt, giving a net cash position of -193.60 million or -40.47 per share.
| Cash & Cash Equivalents | 762,388 |
| Total Debt | 194.37M |
| Net Cash | -193.60M |
| Net Cash Per Share | -40.47 |
| Equity (Book Value) | 34.43M |
| Book Value Per Share | 7.20 |
| Working Capital | -7.54M |
Cash Flow
In the last 12 months, operating cash flow was 13.52 million and capital expenditures -1.40 million, giving a free cash flow of 12.13 million.
| Operating Cash Flow | 13.52M |
| Capital Expenditures | -1.40M |
| Free Cash Flow | 12.13M |
| FCF Per Share | 2.54 |
Margins
Gross margin is 46.37%, with operating and profit margins of 5.87% and 7.56%.
| Gross Margin | 46.37% |
| Operating Margin | 5.87% |
| Pretax Margin | 7.83% |
| Profit Margin | 7.56% |
| EBITDA Margin | 6.95% |
| EBIT Margin | 5.87% |
| FCF Margin | 11.49% |
Dividends & Yields
Med Paper does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.23% |
| Shareholder Yield | n/a |
| Earnings Yield | 4.30% |
| FCF Yield | 6.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Med Paper has an Altman Z-Score of 0.46 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.46 |
| Piotroski F-Score | 7 |